Deregulation of FGFR2-driven signalling may result in impaired ductal branching and disabled development of mammary gland during morphogenesis [8, 10], as well as tumour formation and further progression of the disease in adults [41, 42]. This evidence concerns the gene FGFR2 and neoplasm.